Oncolytics Biotech (ONCY) Receivables - Accured (2009)
Oncolytics Biotech (ONCY) posted quarterly Receivables - Accured of $47573.0 for Q4 2009.
Oncolytics Biotech (ONCY) Receivables - Accured (2009) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Receivables - Accured for 1 consecutive years, with $47573.0 the latest figure, recorded in Q4 2009.
- In Q4 2009, Receivables - Accured changed N/A year-over-year to $47573.0; the TTM figure through Dec 2009 stood at $47573.0 (changed N/A YoY), while the FY2009 annual figure was $47573.0, changed N/A from the prior year.
- Receivables - Accured held at $47573.0 in Q4 2009 per ONCY's latest filing.
- Across five years, Receivables - Accured topped out at $47573.0 in Q4 2009 and bottomed at $47573.0 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 47,573.00 |
| Dec 31, 2009 | 47,573.00 |